Risperigamma 4 mg filmsko obložene tablete স্লোভানিয়া - স্লোভেনীয় - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

risperigamma 4 mg filmsko obložene tablete

filmsko obložena tableta - risperidon

Risset 3 mg filmsko obložene tablete স্লোভানিয়া - স্লোভেনীয় - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

risset 3 mg filmsko obložene tablete

pliva ljubljana d.o.o., ljubljana - filmsko obložena tableta - risperidon

Risset 2 mg filmsko obložene tablete স্লোভানিয়া - স্লোভেনীয় - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

risset 2 mg filmsko obložene tablete

pliva ljubljana d.o.o., ljubljana - risperidon - filmsko obložena tableta - risperidon 2 mg / 1 tableta - risperidon

Risset 1 mg filmsko obložene tablete স্লোভানিয়া - স্লোভেনীয় - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

risset 1 mg filmsko obložene tablete

pliva ljubljana d.o.o., ljubljana - filmsko obložena tableta - risperidon

Torendo 4 mg filmsko obložene tablete স্লোভানিয়া - স্লোভেনীয় - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

torendo 4 mg filmsko obložene tablete

krka, d.d., novo mesto - risperidon - filmsko obložena tableta - risperidon 4 mg / 1 tableta - risperidon

Torendo Q-Tab 2 mg orodisperzibilne tablete স্লোভানিয়া - স্লোভেনীয় - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

torendo q-tab 2 mg orodisperzibilne tablete

krka, d.d., novo mesto - risperidon - orodisperzibilna tableta - risperidon 2 mg / 1 tableta - risperidon

Tibsovo ইউরোপীয় ইউনিয়ন - স্লোভেনীয় - EMA (European Medicines Agency)

tibsovo

les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antineoplastična sredstva - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.

Nimotop 0,2 mg/ml raztopina za infundiranje স্লোভানিয়া - স্লোভেনীয় - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

nimotop 0,2 mg/ml raztopina za infundiranje

bayer d.o.o. - nimodipin - raztopina za infundiranje - nimodipin 0,2 mg / 1 ml - nimodipin

Zavicefta ইউরোপীয় ইউনিয়ন - স্লোভেনীয় - EMA (European Medicines Agency)

zavicefta

pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - antibacterials za sistemsko uporabo, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. upoštevati je treba uradne smernice za ustrezno uporabo protibakterijsko agenti.

Cefazolin Hospira 1 g prašek za raztopino za injiciranje/infundiranje স্লোভানিয়া - স্লোভেনীয় - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

cefazolin hospira 1 g prašek za raztopino za injiciranje/infundiranje

hospira uk ltd. - cefazolin - prašek za raztopino za injiciranje/infundiranje - cefazolin 1 g / 1 viala - cefazolin